This case study shares the journey of a Chinese patient with astrocytic glioma (WHO Grade 3) who sought advanced treatment guidance through Medebound HEALTH’s international telemedicine platform. By connecting with Professor Patrick, Director of Neuro-Oncology at Harvard’s Dana-Farber Cancer Institute, the family received recommendations for advanced genetic testing, targeted therapies, immunotherapy, and clinical trial opportunities. The consultation provided new hope.

This article shows how online second opinions from top U.S. hospitals can give pancreatic cancer patients clearer options, faster access to expertise, and greater confidence in treatment decisions—no matter where they live.

This article explores how Asian patients with bipolar disorder have achieved treatment success by accessing personalized care from top U.S. experts through telemedicine. Learn how these patients benefited from cutting-edge treatments, collaborative care plans, and culturally sensitive support bridging the gap in mental health services for Asian communities.